Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Chen, Jie ^a   Alexander, J Steven ^b   Orr, A Wayne ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALPHA4 BETA1 ANTAGONIST; ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 1; ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CILENGITIDE; ENDOTHELIN 1; EPTIFIBATIDE; IMGN 388; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; JSM 6427; LIGAND; NATALIZUMAB; PLATELET DERIVED GROWTH FACTOR; PROTEIN INHIBITOR; SCATTER FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1ALPHA; SYNAPTOPHYSIN; THROMBOSPONDIN; THROMBOSPONDIN 1; TIROFIBAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN C; VEDOLIZUMAB; VERY LATE ACTIVATION ANTIGEN 4; VOLOCIXIMAB;

BREAST CARCINOMA; CANCER CELL; CANCER MODEL; CANCER MORTALITY; CANCER STAGING; CANCER THERAPY; CHEMOTAXIS; CLINICAL TRIAL (TOPIC); COLON CARCINOMA; CROHN DISEASE; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; IMMUNOSURVEILLANCE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MELANOMA; METASTASIS; MULTIPLE CANCER; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVIEW; SKIN CARCINOGENESIS; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CARCINOMA;

EID: 84863338655     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/853703     Document Type: Review

References (123)

1. Fldi M., Strssenreuther R., Foundations of Manual Lymph Drainage 2004 3rd New York, NY, USA Elsevier
2. Komarova Y., Malik A. B., Regulation of endothelial permeability via paracellular and transcellular transport pathways Annual Review of Physiology 2009 72 463 493
3. Weller R. O., Galea I., Carare R. O., Minagar A., Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis Pathophysiology 2010 17 4 295 306
4. Oliver G., Lymphatic vasculature development Nature Reviews Immunology 2004 4 1 35 45 (Pubitemid 38084130)
5. Gunn M. D., Tangemann K., Tam C., Cyster J. G., Rosen S. D., Williams L. T., A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes Proceedings of the National Academy of Sciences of the United States of America 1998 95 1 258 263 (Pubitemid 28103941)
6. Saeki H., Moore A. M., Brown M. J., Hwang S. T., Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes Journal of Immunology 1999 162 5 2472 2475 (Pubitemid 29309263)
7. Sainte-Marie G., The lymph node revisited: development, morphology, functioning, and role in triggering primary immune responses Anatomical Record 2010 293 2 320 337
8. Levick J. R., Jordan D., Marshall J., Changing perspectives on microvascular fluid exchange Cardiovascular Regulation 1999 London, UK Portland Press 127 152
9. Maby-El Hajjami H., Petrova T. V., Developmental and pathological lymphangiogenesis: from models to human disease Histochemistry and Cell Biology 2008 130 6 1063 1078
10. Tammela T., Alitalo K., Lymphangiogenesis: molecular mechanisms and future promise Cell 2010 140 4 460 476
11. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E., M D. M., Functionally specialized junctions between endothelial cells of lymphatic vessels Journal of Experimental Medicine 2007 204 10 2349 2362 (Pubitemid 47529321)
12. Tammela T., Saaristo A., Holopainen T., Lyytikk J., Kotronen A., Pitkonen M., Abo-Ramadan U., Yl-Herttuala S., Petrova T. V., Alitalo K., Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation Nature Medicine 2007 13 12 1458 1466 (Pubitemid 350224251)
13. Hong Y. K., Lange-Asschenfeldt B., Velasco P., Hiraicawa S., Kunstfeld R., Brown L. F., Bohlen P., Senger D. R., Detmar M., VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the 1 1 and 2 1 integrins FASEB Journal 2004 18 10 1111 1113 (Pubitemid 39561540)
14. Grimaldo S., Yuen D., Ecoiffier T., Chen L., Very late antigen-1 mediates corneal lymphangiogenesis Investigative Ophthalmology Visual Science 2011 52 7 4808 4812
15. Dietrich T., Onderka J., Bock F., Kruse F. E., Vossmeyer D., Stragies R., Zahn G., Cursiefen C., Inhibition of inflammatory lymphangiogenesis by integrin 5 blockade American Journal of Pathology 2007 171 1 361 372 (Pubitemid 47339252)
16. Okazaki T., Ni A., Ayeni O. A., Baluk P., Yao L. C., Vossmeyer D., Zischinsky G., Zahn G., Knolle J., Christner C., M D. M., 5 1 integrin blockade inhibits lymphangiogenesis in airway inflammation American Journal of Pathology 2009 174 6 2378 2387
17. Desgrosellier J. S., Cheresh D. A., Integrins in cancer: biological implications and therapeutic opportunities Nature Reviews Cancer 2010 10 1 9 22
18. Millard M., Odde S., Neamati N., Integrin targeted therapeutics Theranostics 2011 1 154 188
19. Stupp R., Ruegg C., Integrin inhibitors reaching the clinic Journal of Clinical Oncology 2007 25 13 1637 1638 (Pubitemid 46797938)
20. Garmy-Susini B., Makale M., Fuster M., Varner J. A., Methods to study lymphatic vessel integrins Methods in Enzymology 2007 426 415 438
21. van der Flier A., Badu-Nkansah K., Whittaker C. A., Crowley D., Bronson R. T., Lacy-Hulbert A., Hynes R. O., Endothelial 5 and v integrins cooperate in remodeling of the vasculature during development Development 2010 137 14 2439 2449
22. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A. F., Sheppard D., Makinen T., Integrin- 9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis Developmental Cell 2009 17 2 175 186
23. Huang X. Z., Wu J. F., Ferrando R., Lee J. H., Wang Y. L., Farese R. V., Sheppard D., Fatal bilateral chylothorax in mice lacking the integrin 9 1 Molecular and Cellular Biology 2000 20 14 5208 5215 (Pubitemid 30431573)
24. Ma G. C., Liu C. S., Chang S. P., Yeh K. T., Ke Y. Y., Chen T. H., Wang B. B. T., Kuo S. J., Shih J. C., Chen M., A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy Prenatal Diagnosis 2008 28 11 1057 1063 (Pubitemid 352789474)
25. Oommen S., Gupta S. K., Vlahakis N. E., Vascular Endothelial Growth Factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin 9 1: identification of a specific 9 1 binding site Journal of Biological Chemistry 2011 286 2 1083 1092
26. Vlahakis N. E., Young B. A., Atakilit A., Sheppard D., The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin 9 1 Journal of Biological Chemistry 2005 280 6 4544 4552 (Pubitemid 40288622)
27. Brideau G., Mkinen M. J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., Heljasvaara R., Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice Cancer Research 2007 67 24 11528 11535
28. Ou J., Li J., Pan F., Xie G., Zhou Q., Huang H., Liang H., Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain a and integrin 9 Journal of Cellular Biochemistry 2011 112 8 2106 2114
29. Garmy-Susini B., Avraamides C. J., Schmid M. C., Foubert P., Ellies L. G., Barnes L., Feral C., Papayannopoulou T., Lowy A., Blair S. L., Cheresh D., Ginsberg M., Varner J. A., Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis Cancer Research 2010 70 8 3042 3051
30. Larrieu-Lahargue F., Welm A. L., Thomas K. R., Li D. Y., Netrin-4 activates endothelial integrin 6 1 Circulation Research 2011 109 7 770 774
31. Larrieu-Lahargue F., Welm A. L., Thomas K. R., Li D. Y., Netrin-4 induces lymphangiogenesis in vivo Blood 2010 115 26 5418 5426
32. Sporn M. B., The war on cancer Lancet 1996 347 9012 1377 1381 (Pubitemid 26147937)
33. Achen M. G., McColl B. K., Stacker S. A., Focus on lymphangiogenesis in tumor metastasis Cancer Cell 2005 7 2 121 127 (Pubitemid 40248338)
34. Malur S., Krause N., Khler C., Schneider A., Sentinel lymph node detection in patients with cervical cancer Gynecologic Oncology 2001 80 2 254 257 (Pubitemid 32158467)
35. Beahrs O. H., Surgery of the head and neck18961982 Surgery Gynecology and Obstetrics 1983 157 2 180 184
36. Leong S. P. L., Witte M. H., Future perspectives for cancer metastasis and the lymphovascular system Cancer and Metastasis Reviews 2006 25 2 293 294 (Pubitemid 43886404)
37. Kyzas P. A., Geleff S., Batistatou A., Agnantis N. J., Stefanou D., Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma Journal of Pathology 2005 206 2 170 177 (Pubitemid 40754020)
38. Sleeman J. P., Thiele W., Tumor metastasis and the lymphatic vasculature International Journal of Cancer 2009 125 12 2747 2756
39. Less J. R., Posner M. C., Boucher Y., Borochovitz D., Wolmark N., Jain R. K., Interstitial hypertension in human breast and colorectal tumors Cancer Research 1992 52 22 6371 6374
40. Cao R., Bjrndahl M. A., Religa P., Clasper S., Garvin S., Galter D., Meister B., Ikomi F., Tritsaris K., Dissing S., Ohhashi T., Jackson D. G., Cao Y., PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis Cancer Cell 2004 6 4 333 345 (Pubitemid 39361435)
41. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO Journal 1996 15 2 290 298 (Pubitemid 26029207)
42. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., Detmar M., Hepatocyte growth factor promotes lymphatic vessel formation and function EMBO Journal 2005 24 16 2885 2895 (Pubitemid 43079892)
43. Morisada T., Oike Y., Yamada Y., Urano T., Akao M., Kubota Y., Maekawa H., Kimura Y., Ohmura M., Miyamoto T., Nozawa S., Koh G. Y., Alitalo K., Suda T., Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation Blood 2005 105 12 4649 4656 (Pubitemid 40807284)
44. Nagy J. A., Vasile E., Feng D., Sundberg C., Brown L. F., Detmar M. J., Lawitts J. A., Benjamin L., Tan X., Manseau E. J., Dvorak A. M., Dvorak H. F., Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis Journal of Experimental Medicine 2002 196 11 1497 1506 (Pubitemid 35424943)
45. Shin J. W., Min M., Larrieu-Lahargue F., Canron X., Kunstfeld R., Nguyen L., Henderson J. E., Bikfalvi A., Detmar M., Hong Y. K., Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis Molecular Biology of the Cell 2006 17 2 576 584 (Pubitemid 43191094)
46. Spinella F., Garrafa E., Castro V. D., Rosan L., Nicotra M. R., Caruso A., Natali P. G., Bagnato A., Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade Cancer Research 2009 69 6 2669 2676
47. Tammela T., Petrova T. V., Alitalo K., Molecular lymphangiogenesis: new players Trends in Cell Biology 2005 15 8 434 441 (Pubitemid 41125775)
48. Tugues S., Koch S., Gualandi L., Li X., Claesson-Welsh L., Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer Molecular Aspects of Medicine 2011 32 2 88 111
49. Grothey A., Galanis E., Targeting angiogenesis: progress with anti-VEGF treatment with large molecules Nature Reviews Clinical Oncology 2009 6 9 507 518
50. Achen M. G., Jeltsch M., Kukk E., Mkinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A., Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 548 553 (Pubitemid 28083780)
51. Tobler N. E., Detmar M., Tumor and lymph node lymphangiogenesisimpact on cancer metastasis Journal of Leukocyte Biology 2006 80 4 691 696 (Pubitemid 44835883)
52. Hirakawa S., Brown L. F., Kodama S., Paavonen K., Alitalo K., Detmar M., VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites Blood 2007 109 3 1010 1017 (Pubitemid 46220646)
53. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L. F., Detmar M., VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis Journal of Experimental Medicine 2005 201 7 1089 1099 (Pubitemid 40524677)
54. He X. W., Yu X., Liu T., Yu S. Y., Chen D. J., Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice Chinese Medical Journal 2008 121 5 439 444 (Pubitemid 351565992)
55. He Y., Kozaki K. I., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., Alitalo K., Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling Journal of the National Cancer Institute 2002 94 11 819 825 (Pubitemid 34705053)
56. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., Alitalo K., Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels Cancer Research 2005 65 11 4739 4746 (Pubitemid 40740810)
57. Good D. J., Polverini P. J., Rastinejad F., Le Beau M. M., Lemons R. S., Frazier W. A., Bouck N. P., A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proceedings of the National Academy of Sciences of the United States of America 1990 87 17 6624 6628
58. Cursiefen C., Maruyama K., Bock F., Saban D., Sadrai Z., Lawler J., Dana R., Masli S., Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes Journal of Experimental Medicine 2011 208 5 1083 1092
59. Hawighorst T., Oura H., Streit M., Janes L., Nguyen L., Brown L. F., Oliver G., Jackson D. G., Detmar M., Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice Oncogene 2002 21 52 7945 7956 (Pubitemid 35430606)
60. Oka M., Iwata C., Suzuki H. I., Kiyono K., Morishita Y., Watabe T., Komuro A., Kano M. R., Miyazono K., Inhibition of endogenous TGF-2 signaling enhances lymphangiogenesis Blood 2008 111 9 4571 4579
61. Schultz-Cherry S., Murphy-Ullrich J. E., Thrombospondin causes activation of latent transforming growth factor- secreted by endothelial cells by a novel mechanism Journal of Cell Biology 1993 122 4 923 932 (Pubitemid 23241101)
62. Bruyre F., Melen-Lamalle L., Blacher S., Roland G., Thiry M., Moons L., Frankenne F., Carmeliet P., Alitalo K., Libert C., Sleeman J. P., Foidart J. M., Nol A., Modeling lymphangiogenesis in a three-dimensional culture system Nature Methods 2008 5 5 431 437 (Pubitemid 351619102)
63. Heishi T., Hosaka T., Suzuki Y., Miyashita H., Oike Y., Takahashi T., Nakamura T., Arioka S., Mitsuda Y., Takakura T., Hojo K., Matsumoto M., Yamauchi C., Ohta H., Sonoda H., Sato Y., Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis American Journal of Pathology 2010 176 4 1950 1958
64. Kojima T., Azar D. T., Chang J. H., Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis FEBS Letters 2008 582 17 2515 2520
65. Albuquerque R. J. C., Hayashi T., Cho W. G., Kleinman M. E., Dridi S., Takeda A., Baffi J. Z., Yamada K., Kaneko H., Green M. G., Chappell J., Wilting J., Weich H. A., Yamagami S., Amano S., Mizuki N., Alexander J. S., Peterson M. L., Brekken R. A., Hirashima M., Capoor S., Usui T., Ambati B. K., Ambati J., Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth Nature Medicine 2009 15 9 1023 1030
66. Issa A., Le T. X., Shoushtari A. N., Shields J. D., Swartz M. A., Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype Cancer Research 2009 69 1 349 357
67. Shields J. D., Emmett M. S., Dunn D. B. A., Joory K. D., Sage L. M., Rigby H., Mortimer P. S., Orlando A., Levick J. R., Bates D. O., Chemokine-mediated migration of melanoma cells towards lymphaticsa mechanism contributing to metastasis Oncogene 2007 26 21 2997 3005 (Pubitemid 46733648)
68. Wiley H. E., Gonzalez E. B., Maki W., Wu M. T., Hwang S. T., Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma Journal of the National Cancer Institute 2001 93 21 1638 1643 (Pubitemid 33094871)
69. Liu Y., Ji R., Li J., Gu Q., Zhao X., Sun T., Wang J., Li J., Du Q., Sun B., Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis Journal of Experimental and Clinical Cancer Research 2010 29 1, article no. 16
70. Cunningham H. D., Shannon L. A., Calloway P. A., Fassold B. C., Dunwiddie I., Vielhauer G., Zhang M., Vines C. M., Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the Lymph nodes in mice Translational Oncology 2010 3 6 354 361
71. Furusato B., Mohamed A., Uhlén M., Rhim J. S., CXCR4 and cancer: review article Pathology International 2010 60 7 497 505
72. Liu J., Liao S., Huang Y., Samuel R., Shi T., Naxerova K., Huang P., Kamoun W., Jain R. K., Fukumura D., Xu L., PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer Clinical Cancer Research 2011 17 11 3638 3648
73. Chang S. C., Lin P. C., Yang S. H., Wang H. S., Li A. F. Y., Lin J. K., SDF-1 G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer Annals of Surgical Oncology 2009 16 8 2323 2330
74. Yurchenco P. D., Amenta P. S., Patton B. L., Basement membrane assembly, stability and activities observed through a developmental lens Matrix Biology 2004 22 7 521 538 (Pubitemid 38283776)
75. Arroyo A. G., Iruela-Arispe M. L., Extracellular matrix, inflammation, and the angiogenic response Cardiovascular Research 2010 86 2 226 235
76. Valenick L. V., Hsia H. C., Schwarzbauer J. E., Fibronectin fragmentation promotes 4 1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix Experimental Cell Research 2005 309 1 48 55 (Pubitemid 41191222)
77. Bornstein P., Sage E. H., Matricellular proteins: extracellular modulators of cell function Current Opinion in Cell Biology 2002 14 5 608 616 (Pubitemid 35247745)
78. Murphy-Ullrich J. E., The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? Journal of Clinical Investigation 2001 107 7 785 790 (Pubitemid 32274027)
79. Schwartz M. A., Integrin signaling revisited Trends in Cell Biology 2001 11 12 466 470 (Pubitemid 33079137)
80. Frisch S. M., Screaton R. A., Anoikis mechanisms Current Opinion in Cell Biology 2001 13 5 555 562 (Pubitemid 32817013)
81. Bissell M. J., Aggeler J., Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? Progress in Clinical and Biological Research 1987 249 251 262
82. Folkman J., Kalluri R., Cancer without disease Nature 2004 427 6977 787 (Pubitemid 38297724)
83. van den Hooff A., Stromal Involvement In Malignant Growth Advances in Cancer Research 1988 50 159 196
84. Wernert N., The multiple roles of tumour stroma Virchows Archiv 1997 430 6 433 443 (Pubitemid 27322961)
85. Kopfstein L., Christofori G., Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment Cellular and Molecular Life Sciences 2006 63 4 449 468
86. van der Flier A., Sonnenberg A., Function and interactions of integrins Cell and Tissue Research 2001 305 3 285 298 (Pubitemid 34212122)
87. Hynes R. O., Integrins: bidirectional, allosteric signaling machines Cell 2002 110 6 673 687 (Pubitemid 35283958)
88. Geiger B., Yamada K. M., Molecular architecture and function of matrix adhesions Cold Spring Harbor perspectives in biology 2011 3 5
89. Calderwood D. A., Shattil S. J., Ginsberg M. H., Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling Journal of Biological Chemistry 2000 275 30 22607 22610 (Pubitemid 30646138)
90. Legate K. R., Fssler R., Mechanisms that regulate adaptor binding to -integrin cytoplasmic tails Journal of Cell Science 2009 122, part 2 187 198
91. Heasman S. J., Ridley A. J., Mammalian Rho GTPases: new insights into their functions from in vivo studies Nature Reviews Molecular Cell Biology 2008 9 9 690 701
92. Hogan B. M., Bos F. L., Bussmann J., Witte M., Chi N. C., Duckers H. J., Schulte-Merker S., Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting Nature Genetics 2009 41 4 396 398
93. Bos F. L., Caunt M., Peterson-Maduro J., Planas-Paz L., Kowalski J., Karpanen T., Van Impel A., Tong R., Ernst J. A., Korving J., Van Es J. H., Lammert E., Duckers H. J., Schulte-Merker S., CCBE1 Is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-c in vivo Circulation Research 2011 109 5 486 491
94. White E. S., Baralle F. E., Muro A. F., New insights into form and function of fibronectin splice variants Journal of Pathology 2008 216 1 1 14
95. Ou J. J., Wu F., Liang H. J., Colorectal tumor derived fibronectin alternatively spliced EDA domain exserts lymphangiogenic effect on human lymphatic endothelial cells Cancer Biology and Therapy 2010 9 3 186 191
96. Sanz-Rodrguez F., Hidalgo A., Teixid J., Chemokine stromal cell-derived factor-1 modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1 Blood 2001 97 2 346 351 (Pubitemid 32060316)
97. Allan A. L., George R., Vantyghem S. A., Lee M. W., Hodgson N. C., Engel C. J., Holliday R. L., Girvan D. P., Scott L. A., Postenka C. O., Al-Katib W., Stitt L. W., Uede T., Chambers A. F., Tuck A. B., Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer American Journal of Pathology 2006 169 1 233 246
98. Orend G., Chiquet-Ehrismann R., Tenascin-C induced signaling in cancer Cancer Letters 2006 244 2 143 163 (Pubitemid 44508708)
99. Clasper S., Royston D., Baban D., Cao Y., Ewers S., Butz S., Vestweber D., Jackson D. G., A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis Cancer Research 2008 68 18 7293 7303
100. Podgrabinska S., Braun P., Velasco P., Kloos B., Pepper M. S., Jackson D. G., Skobe M., Molecular characterization of lymphatic endothelial cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16069 16074 (Pubitemid 35462750)
101. Solito R., Alessandrini C., Fruschelli M., Pucci A. M., Gerli R., An immunological correlation between the anchoring filaments of initial lymph vessels and the neighboring elastic fibers: a unified morphofunctional concept Lymphology 1997 30 4 194 202 (Pubitemid 28067056)
102. Gerli R., Solito R., Weber E., Aglian M., Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics Lymphology 2000 33 4 148 157 (Pubitemid 32063545)
103. Mkinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E. C., Wise L., Mercer A., Kowalski H., Kerjaschki D., Stacker S. A., Achen M. G., Alitalo K., Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 EMBO Journal 2001 20 17 4762 4773 (Pubitemid 32848629)
104. Petrova T. V., Mkinen T., Mkel T. P., Saarela J., Virtanen I., Ferrell R. E., Finegold D. N., Kerjaschki D., Yl-Herttuala S., Alitalo K., Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor EMBO Journal 2002 21 17 4593 4599 (Pubitemid 34984346)
105. Bax D. V., Bernard S. E., Lomas A., Morgan A., Humphries J., Shuttleworth C. A., Humphries M. J., Kielty C. M., Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by 5 1 and v 3 integrins Journal of Biological Chemistry 2003 278 36 34605 34616
106. Pereira L., Andrikopoulos K., Tian J., Lee S. Y., Keene D. R., Ono R., Reinhardt D. P., Sakai L. Y., Biery N. J., Bunton T., Dietz H. C., Ramirez F., Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome Nature Genetics 1997 17 2 218 222
107. Danussi C., Spessotto P., Petrucco A., Wassermann B., Sabatelli P., Montesi M., Doliana R., Bressan G. M., Colombatti A., Emilin1 deficiency causes structural and functional defects of lymphatic vasculature Molecular and Cellular Biology 2008 28 12 4026 4039 (Pubitemid 351812988)
108. Verdone G., Doliana R., Corazza A., Colebrooke S. A., Spessotto P., Bot S., Bucciotti F., Capuano A., Silvestri A., Viglino P., Campbell I. D., Colombatti A., Esposito G., The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the 4 1 integrin Journal of Biological Chemistry 2008 283 27 18947 18956
109. Hong Y. K., Detmar M., Prox1, master regulator of the lymphatic vasculature phenotype Cell and Tissue Research 2003 314 1 85 92 (Pubitemid 37409915)
110. Mishima K., Watabe T., Saito A., Yoshimatsu Y., Imaizumi N., Masui S., Hirashima M., Morisada T., Oike Y., Araie M., Niwa H., Kubo H., Suda T., Miyazono K., Prox1 induces lymphatic endothelial differentiation via integrin 9 and other signaling cascades Molecular Biology of the Cell 2007 18 4 1421 1429 (Pubitemid 46626636)
111. Liao Y. F., Gotwals P. J., Koteliansky V. E., Sheppard D., Van Water L. D., The EIIIA segment of fibronectin is a ligand for integrins 9 1 and 9 1 providing a novel mechanism for regulating cell adhesion by alternative splicing Journal of Biological Chemistry 2002 277 17 14467 14474 (Pubitemid 34952511)
112. Sudhakar A., Sugimoto H., Yang C., Lively J., Zeisberg M., Kalluri R., Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by v and 5 1 integrins Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4766 4771 (Pubitemid 36457804)
113. Féral C. C., Rose D. M., Han J., Fox N., Silverman G. J., Kaushansky K., Ginsberg M. H., Blocking the 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site Journal of Clinical Investigation 2006 116 3 715 723 (Pubitemid 43326880)
114. Arakawa H., Netrin-1 and its receptors in tumorigenesis Nature Reviews Cancer 2004 4 12 978 987 (Pubitemid 39626221)
115. Sheridan C., Fast track to MS drug Nature Biotechnology 2004 22 8 939 941 (Pubitemid 39014461)
116. Huggett B., How Tysabri survived Nature Biotechnology 2009 27 11 986
117. Grivennikov S. I., Greten F. R., Karin M., Immunity, inflammation, and cancer Cell 2010 140 6 883 899
118. Schreiber R. D., Old L. J., Smyth M. J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 2011 331 6024 1565 1570
119. Sica A., Larghi P., Mancino A., Rubino L., porta C., Totaro M. G., Rimoldi M., Biswas S. K., Allavena P., Mantovani A., Macrophage polarization in tumour progression Seminars in Cancer Biology 2008 18 5 349 355
120. Condeelis J., Pollard J. W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 2006 124 2 263 266 (Pubitemid 43121975)
121. Murdoch C., Muthana M., Coffelt S. B., Lewis C. E., The role of myeloid cells in the promotion of tumour angiogenesis Nature Reviews Cancer 2008 8 8 618 631
122. Jin H., Su J., Garmy-Susini B., Kleeman J., Varner J., Integrin 4 1 promotes monocyte trafficking and angiogenesis in tumors Cancer Research 2006 66 4 2146 2152
123. Swann J. B., Smyth M. J., Immune surveillance of tumors Journal of Clinical Investigation 2007 117 5 1137 1146 (Pubitemid 46718398)